BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11308020)

  • 21. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans.
    Chandrasekaran EV; Xue J; Neelamegham S; Matta KL
    Carbohydr Res; 2006 Jun; 341(8):983-94. PubMed ID: 16545347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.
    Marcos NT; Cruz A; Silva F; Almeida R; David L; Mandel U; Clausen H; Von Mensdorff-Pouilly S; Reis CA
    J Histochem Cytochem; 2003 Jun; 51(6):761-71. PubMed ID: 12754287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucin oligosaccharide biosynthesis in human colonic cancerous tissues and cell lines.
    Dahiya R; Itzkowitz SH; Byrd JC; Kim YS
    Cancer; 1992 Sep; 70(6):1467-76. PubMed ID: 1515998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucin-type O-glycosylation in Fasciola hepatica: characterisation of carcinoma-associated Tn and sialyl-Tn antigens and evaluation of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase activity.
    Freire T; Casaravilla C; Carmona C; Osinaga E
    Int J Parasitol; 2003 Jan; 33(1):47-56. PubMed ID: 12547345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing the intra-Golgi pH of cultured LS174T goblet-differentiated cells mimics the decreased mucin sulfation and increased Thomsen-Friedenreich antigen (Gal beta1-3GalNac alpha-) expression seen in colon cancer.
    Campbell BJ; Rowe GE; Leiper K; Rhodes JM
    Glycobiology; 2001 May; 11(5):385-93. PubMed ID: 11425799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-Golgi apparatus inhibits the development of core-2-based O-glycans.
    Whitehouse C; Burchell J; Gschmeissner S; Brockhausen I; Lloyd KO; Taylor-Papadimitriou J
    J Cell Biol; 1997 Jun; 137(6):1229-41. PubMed ID: 9182658
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammalian sialyltransferase ST3Gal-II: its exchange sialylation catalytic properties allow labeling of sialyl residues in mucin-type sialylated glycoproteins and specific gangliosides.
    Chandrasekaran EV; Xue J; Xia J; Locke RD; Patil SA; Neelamegham S; Matta KL
    Biochemistry; 2011 Nov; 50(44):9475-87. PubMed ID: 21913655
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity.
    Julien S; Adriaenssens E; Ottenberg K; Furlan A; Courtand G; Vercoutter-Edouart AS; Hanisch FG; Delannoy P; Le Bourhis X
    Glycobiology; 2006 Jan; 16(1):54-64. PubMed ID: 16135558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
    Gerken TA
    Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in gastric mucin with malignant transformation: novel pathway for mucin synthesis.
    Yamashita Y; Chung YS; Horie R; Kannagi R; Sowa M
    J Natl Cancer Inst; 1995 Mar; 87(6):441-6. PubMed ID: 7532228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Cosmc connection to the Tn antigen in cancer.
    Ju T; Aryal RP; Kudelka MR; Wang Y; Cummings RD
    Cancer Biomark; 2014 Jan; 14(1):63-81. PubMed ID: 24643043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen.
    Marcos NT; Pinho S; Grandela C; Cruz A; Samyn-Petit B; Harduin-Lepers A; Almeida R; Silva F; Morais V; Costa J; Kihlberg J; Clausen H; Reis CA
    Cancer Res; 2004 Oct; 64(19):7050-7. PubMed ID: 15466199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of a core 3 disialyl-Le(x) hexasaccharide in human colorectal cancers: a potential marker of malignant transformation in colon.
    Robbe-Masselot C; Herrmann A; Maes E; Carlstedt I; Michalski JC; Capon C
    J Proteome Res; 2009 Feb; 8(2):702-11. PubMed ID: 19152289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of mucin synthesis by benzyl-alpha-GalNAc in KATO III gastric cancer and Caco-2 colon cancer cells.
    Byrd JC; Dahiya R; Huang J; Kim YS
    Eur J Cancer; 1995; 31A(9):1498-505. PubMed ID: 7577079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of O-glycan core 3: characterization of UDP-GlcNAc: GalNAc-R beta 3-N-acetyl-glucosaminyltransferase activity from colonic mucosal tissues and lack of the activity in human cancer cell lines.
    Vavasseur F; Yang JM; Dole K; Paulsen H; Brockhausen I
    Glycobiology; 1995 May; 5(3):351-7. PubMed ID: 7655172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa.
    Ogata S; Koganty R; Reddish M; Longenecker BM; Chen A; Perez C; Itzkowitz SH
    Glycoconj J; 1998 Jan; 15(1):29-35. PubMed ID: 9530954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two different glycosyltransferase defects that result in GalNAc alpha-O-peptide (Tn) expression.
    King MJ; Chan A; Roe R; Warren BF; Dell A; Morris HR; Bartolo DC; Durdey P; Corfield AP
    Glycobiology; 1994 Jun; 4(3):267-79. PubMed ID: 7949653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered O-linked glycosylation in benign and malignant meningiomas.
    Talabnin C; Trasaktaweesakul T; Jaturutthaweechot P; Asavaritikrai P; Kongnawakun D; Silsirivanit A; Araki N; Talabnin K
    PeerJ; 2024; 12():e16785. PubMed ID: 38274327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Site-specific core 1 O-glycosylation pattern of the porcine submaxillary gland mucin tandem repeat. Evidence for the modulation of glycan length by peptide sequence.
    Gerken TA; Owens CL; Pasumarthy M
    J Biol Chem; 1998 Oct; 273(41):26580-8. PubMed ID: 9756896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of incomplete O-glycan synthesis in MCF-7 breast cancer cells: putative role of MUC6 in Tn antigen expression.
    Freire T; Bay S; von Mensdorff-Pouilly S; Osinaga E
    Cancer Res; 2005 Sep; 65(17):7880-7. PubMed ID: 16140958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.